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abstract
PURPOSE Although new therapeutic options continue to improve disease-related outcomes in advanced breast
cancer (ABC), enhanced focus is needed to improve quality of life for patients currently living with ABC.
METHODS In November 2019, a multidisciplinary workshop to explore patient perceptions of their information
and support needs was held at the ABC Global Alliance Annual Meeting in Lisbon, Portugal. Ninety-two at-
tendees from 27 countries participated in the workshop.
RESULTS Several key unmet needs were identified and discussed in the workshop, including the following:
(1) Significant patient knowledge gaps exist related to the diagnosis and management of ABC, and the
availability of patient-focused information to support these gaps in knowledge remains limited. (2) The de-
velopment of meaningful relationships between patients and health care professionals, and the role of patients in
decision making, is often overlooked for patients with ABC. (3) Multidisciplinary care approaches are crucial for
patients with ABC; however, these often lack effective coordination. (4) Access to clinical trials for ABC also
remains limited. (5) Caregivers, friends, and family members do not receive sufficient guidance to support
patients with ABC and manage their own well-being.
CONCLUSION The variety of unmet needs explored in the workshop demonstrates that patients with ABC still face
considerable challenges related to quality of care and support, which will not be resolved until tangible action is
taken. Issues highlighted in the workshop should be prioritized by working groups to shape the development of
community-based solutions. There is a need for the global community to act proactively to maximize awareness
of these ongoing unmet needs and existing resources, while socializing and building new initiatives and re-
sources that will help to close these gaps for patients.
JCO Global Oncol 7:976-984. © 2021 by American Society of Clinical Oncology
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INTRODUCTION
Although recent innovations in disease understand-
ing and treatment have led to a high 5-year survival
rate for patients diagnosed with early breast cancer
(EBC), the same is not true for advanced breast
cancer (ABC). Fewer than three in 10 people live
more than 5 years after diagnosis of ABC, highlighting
a critical need for continuous advances in treatment
and management to improve outcomes.1,2 The pri-
mary aims of most new therapeutic options are fo-
cused on disease-related outcomes, but there is a
real need to enhance the quality of life for patients
currently living with ABC.
The ABC Global Alliance conducted amultidisciplinary
workshop at their 2019 Annual Meeting to gain in-
sights into the persistent unmet needs faced by
patients with ABC. Primary themes explored during
the workshop included the value of information
communicated to patients by health care professionals
(HCPs), patients’ experiences living with ABC, and
how caregivers and family members could potentially
enhance patients’ quality of life. This report details
findings from the workshop and highlights initiatives
that the ABC Global Alliance, its members, and the
broader breast cancer community could develop.
METHODS
In November 2019, a workshop was held at the ABC
Global Alliance Annual Meeting in Lisbon to explore
patient perceptions of information and support needs.
Ninety-two multidisciplinary attendees from 27 coun-
tries participated, including patients, patient advocates,
HCPs experienced in ABC (oncologists, nurses, and
psychologists), and pharmaceutical company repre-
sentatives. Further details of participant characteristics
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Attendees were split into multidisciplinary, facilitator-led
groups to discuss the following questions from the pa-
tient perspective:
1. What I wish I had known about ABC and/or metastatic
breast cancer (MBC) before my diagnosis.
2. Things I still do not understand about ABC and/or MBC
and treatment options.
3. Things my health care professionals did that
a. helped
b. did not help.
4. Things friends and family could do to help when you
have ABC and/or MBC.
The group facilitators gathered and documented the in-
sights outlined in this qualitative study.
RESULTS
During the workshop, attendees identified and discussed a
number of key unmet needs that exist for patients living with
ABC, the details of which are outlined in Table 4.
CONTEXT
Key Objective
To enable 92 multidisciplinary participants at a novel advanced breast cancer (ABC) Global Alliance workshop to identify and
discuss the gaps that exist across different health care systems and cultures, in the provision of support and information by
formal and informal careers of people with advanced or metastatic breast cancer.
Knowledge Generated
Despite the advances made in the treatment of ABC, many commonalities were highlighted by this relatively well-informed
diverse group concerning lack of information about therapeutic options, poor written and verbal communication con-
cerning prognosis and impacts on quality of life, and inadequate access to basic support services. Friends and family of
affected individuals often struggled to assist in constructive ways, lacking appropriate education and support themselves.
Relevance
The workshop findings outlined several initiatives that the broader breast cancer community could develop to ensure that the
clinical treatment advances are matched with improvements to the quality of survival of individuals with ABC.
TABLE 1. Participant Age
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DISCUSSION
On the basis of the insights provided by the multidisci-
plinary group, the authors identified opportunities to im-
prove patient understanding and knowledge about ABC,
patient-HCP relationships, and support for caregivers,
family members, and friends. The opportunities identified
are summarized in Table 5.
Patient Perceptions and Knowledge About ABC
1. What I wish I had known about ABC and/or MBC before
my diagnosis.
2. Things I still do not understand about ABC and/or MBC
and treatment options.
Significant patient knowledge gaps exist related to the
diagnosis and management of ABC, and the availability
of patient-focused information to support these gaps
in knowledge remains limited. Key challenges identified
by patients with ABC were a lack of timely and reliable
information about diagnosis, recurrence, prognosis, and
disease management; the impact of ABC on everyday life;
and availability of patient-focused resources. In addition
to health care–related matters, patients highlighted the
need for advice about continuing to work, making a will,
and accessing support for the costs of treatment. Diffi-
culty in obtaining this information left patients feel con-
fused, frustrated, and helpless. Without a clear
understanding of their diagnosis or of the treatment and
support options available, patients felt unable to make
educated choices about their health care and necessary
changes to their lifestyle, negatively affecting their quality
of life.
Before diagnosis of ABC, many of those diagnosed with and
treated for EBC were unaware of the possibility of recur-
rence; the subsequent diagnosis of ABC left patients
shocked, dismayed, and unprepared. However, simply
providing information about the risk of recurrence may not
effectively improve patient understanding. Although 80% of
surgeons and oncologists report discussing recurrence with
their patients with EBC,3 one study cited that only 17% of
patients could accurately describe their risk of recurrence.4
This suggests that the issue may be not only purely a matter
of providing information but also one of the effective
communications—in particular, checking patients’ un-
derstanding of the key symptoms to report, the impact of
recurrence on longer-term survival, and their prognosis.
Some decision-making tools are available to help; for in-
stance, some UK clinicians use a program called NHS
Predict, which evaluates personal information about the
patient and their tumor characteristics to calculate the
potential impact of different treatments on survival out-
comes, on the basis of the results of clinical trials. Outputs
are displayed visually to aid discussion, but are not a
substitute for personalized discussion.5
Effective communication was an overarching theme
throughout the workshop, and participants expanded on
the gaps in discussions about diagnosis. For example, a
variety of terms are often used to describe breast cancer
that has spread to other tissues, beyond the breast. The
terms advanced, metastatic, secondary, and stage IV are
frequently used interchangeably by HCPs, and across
different countries, which can be confusing for patients.6,7
Some information leaflets and resources available online
suffer from the same problem. This is compounded by the
generally low health literacy and numeracy among patients,
irrespective of socioeducational group, who often struggle
to understand medical concepts and terminology.8 One
study found that approximately 50% of patients with EBC
have poor health literacy and informational needs are
higher among those with the worst health literacy.8 There is
a concern that these patients may search for answers from
unreliable sources, ultimately further hindering their
understanding.
Following an ABC diagnosis, in addition to the challenges
surrounding health care education, participants com-
mented on a lack of available and accessible advice on
occupational, legal, and financial support. In some coun-
tries, tax and employment laws exist specifically to assist
those living with cancer; however, patients often do not
know that such support is available, whether they are eli-
gible, or how and where to access it. Although several
charities producematerials concerning these issues,9-12 the
laws and available support are very country-specific and
there is an urgent need for access to accurate information,
nationally and even regionally. Furthermore, language is a
frequent barrier to accessing high-quality resources for
many patients; often, materials exist only in English. Factors
such as support and ongoing family and work commit-
ments can have a significant positive or negative impact on
patients’ lives, ensuring that relevant information is easy to
find, understand, and implement, which could substan-
tially improve patients’ and caregivers’ quality of life.
On the basis of the experience and expertise of the mul-
tidisciplinary participant group, the following opportunities
were identified to improve patient understanding and
knowledge about ABC:
Before or at Diagnosis
• Using patient-friendly language to assist patients with
EBC in their understanding of the risk of recurrence and
its impact on longer-term survival and helping patients to
recognize the importance of adjuvant therapies in re-
ducing the risk of recurrence and the key role that pa-
tients can play in reducing their risk (eg, adhering to drug
regimens).
• Providing accurate and personalized information about
diagnosis and prognosis in an easily understandable
format.
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Post-diagnosis
• Directing patients to appropriate resources for further
research, such as patient advocacy or health service
websites, could enable improved self-education about
ABC and avoid the use of unreliable sources. The ABC
Global Alliance website serves as a central hub and
repository of many resources available worldwide, sev-
eral of which exist in different languages,13 and it is
crucial that both health care teams and patient advo-
cates make these resources known to patients with ABC.
• Developing partnerships between health practices and
local patient groups to provide patients with information
and direction for occupational, legal, and financial
support specific to their country or region could address
some of the daily needs they face while living with ABC.
Access to appropriate information in their native lan-
guage is critical for patients with ABC.
Impact of Health Care Professionals and
Care Coordination
3. Things my health care professionals did that helped or
did not help.
The development of meaningful relationships between
patients and HCPs, and the role of patients in decision
making, can often be overlooked for patients with ABC.
The workshop group defined the need for deeper relation-
ships with HCPs as a key imperative for improved ABC care.
Patients felt that their individual circumstances, values,
needs, and fears were often overlooked when HCPs made
treatment decisions, and many expressed a desire for a
greater role in the decision-making process. Additionally,
patients reported a lack of sufficient empathy from their health
care team, stating that more emphasis should be placed on
the honest but hopeful delivery of information and provision of
support for the emotional challenges that patients face.
It should be acknowledged that there are universal barriers
that hinder the development of meaningful relationships
between patients and HCPs. Foremost is a lack of time
during physician appointments, which, albeit varied among
practices, is often too short to address the emotional needs of
patients. Patients reported that in countries with large ABC
populations and limited human resources, appointments
can be as short as 1-2 minutes. In developed countries, and
particularly in private practice, these may reach 30-60
minutes. The primary focus of physicians during appoint-
ments is to inform and educate patients about diagnosis,
prognosis, and treatment options for ABC, leaving little time
to understand patients’ holistic needs beyond their disease.
However, it is the firm belief of the ABC Global Alliance that
the addition of a few short questions about a patient’s
preferences and well-being is achievable within this time,
crucial for treatment decision making, and could improve
care for these vulnerable patients dramatically. Furthermore,
additional time with other HCPs, particularly trained nurses,
can complement the information provided by oncologists
and clarify remaining questions. The role of specialized
nurses cannot be underestimated in oncology since they are
often the anchor point for patients with ABC.
A secondary barrier to developing patient-HCP relationships is
a lack of ongoing training for HCPs in how to relate em-
pathically to patients and consider their individual needs,
especially among physicians. Although oncologists are
trained to make the most effective treatment decisions for
their patients on the basis of scientific evidence, a lack of
understanding about patient’s lifestyle, cultural or personal
needs, and preferences can prevent delivery of an optimal
patient experience. One opportunity to overcome this gap is
communication skills training, which is now included in the
European Society for Medical Oncology/ASCO global curric-
ulum in medical oncology14 and is progressively being
implemented worldwide. This training is associated with
significant improvement in communication skills that facilitate
empathy and consideration of patient’s needs, preferences,
and concerns, promoting patient-centered care.15 Further-
more, this is associated with a positive impact on patients’
clinical outcomes.16 Although communication training for
oncologists exists in many countries,17 it is usually voluntary
and not consistently adopted. Incorporating mandatory
training at early stages of oncologists’ careers will undoubtedly
improve the skills of the next generations of physicians.
Additionally, shared decision making can have a significant
impact on patient outcomes. Data from multiple disease
areas show that patients who understand their condition
and have an active role in decision making are significantly
more likely to adhere to therapy and experience corre-
sponding improvements in clinical outcomes.18
Multidisciplinary care approaches are crucial for patients
with ABC; however, these often lack effective coordination;
access to clinical trials for ABC also remains limited. In the
absence of effective, coordinated, multidisciplinary care,
patients stated that the multiple needs of ABC treatment
could be confusing and overwhelming, as they interact with a
variety of HCPs and specialties throughout the course of their
treatment. Patients are often uncertain as to who their pri-
mary point of contact should be and who to direct questions
to. Additionally, patients struggle with the substantial emo-
tional burden of living with ABC and many expressed a need
for both professional and peer psychologic support to be
integrated into their care. Unfortunately, many patients
shared that they were unaware of where to find peer support
or who their local patient advocacy groups were and felt that
these resources should bemore accessible and advertised in
hospitals where they receive treatment.
Another unmet need identified in the workshop was limited
access to ABC clinical trials. Currently, many patients with
ABC—such as elderly populations, people with active brain
metastases, and those with comorbidities—are not eligible
to take part in clinical trials, because of strict inclusion and
exclusion criteria. For those who are eligible, many real-life
Gaps in Care and Support for Patients With ABC
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factors prevent participation. Often, the need for clinical
trials to be run by specialist oncology centers places a
geographic limitation on participation, as many patients are
unable to travel long distances. Some patients lack
knowledge about clinical trials and tend to fear the ex-
perimental aspect of treatment, and in particular the
concept of random assignment,19 which is contrary to the
observation that most patients involved in trials are likely to
have better outcomes.
To address these challenges, a revolution in oncologic
clinical research is needed, with the development of trials
focused on clinically relevant questions, appropriate inclu-
sion or exclusion criteria, and meaningful end points. The
logistical burden of clinical trials on patients and HCPs must
also be eased. Furthermore, provision of psychologic care,
expansion of trials, and promotion of trial programs to raise
awareness and educate patients on their benefits could also
help. There is hope that real-world and big data projects will
help to complement clinical trial data, specifically for ABC, to
fill existing gaps in epidemiologic and outcomes data.20-25
These insights have driven the identification of opportu-
nities to improve patient-HCP relationships and foster an
enhanced multidisciplinary care approach:
• Taking time at the beginning of appointments to ask
patients open questions about their emotional well-being
and expectations for therapy could prompt them to
provide additional information that is useful when de-
veloping a treatment plan.
• Providing contact details of the health care team, in-
cluding administrative members, nurses, and physi-
cians, and particularly the patients’ primary point of
contact, could create a channel for patients to ask
questions about their therapy and provide them with a
feeling of support and continuity.
• Engaging patients in the decision-making process by
explaining treatment options and information in an easy to
understand manner could improve patient satisfaction
and outcomes. Cultural differences should also be con-
sidered when engaging patients in treatment decisions, as
individuals from some cultures may feel uncomfortable
about certain approaches. Providing adequate written
information and links to available resources is key to allow
patients to further explore and digest information at home.
• Training HCPs in communication skills that foster em-
pathy could improve their ability to adopt a more holistic
approach that considers individual patient needs and life
circumstances.
• Asking patients how they prefer to receive information,
including test results—for example, via e-mail, telephone,
or face-to-face—could improve their engagement.
• Providing patients with information on the availability of
professional psychologic services and local peer support
groups may help to manage the emotional burden of
living with ABC.
• Designing clinical trials focused on clinically relevant
questions, appropriate inclusion or exclusion criteria,
and meaningful end points could improve access to trials
for patients with ABC, whereas educating on the positive
outcomes associated with trials could reduce fear and
empower patients to participate.
• The generation of real-world data to complement clinical
trial data could help to bridge the current gaps in epi-
demiologic and outcomes data for ABC.
The Role of Caregivers, Friends, and Family
4. Things that friends and family could do to help when you
have ABC.
Caregivers, friends, and family members do not receive
sufficient guidance to support patients with ABC and manage
their own well-being. Despite the crucial role of caregivers,
friends, and family in the lives of peoplewithABC, theworkshop
identifieda lack of accessible guidance, resources, and support
for these individuals. The impact of an ABC diagnosis is far-
reaching and extremely difficult for friends and family, whomay
need support to cope emotionally and practically. Caregivers
are often close relations who are not trained to care for those
living with ABC and must do so alongside other life commit-
ments, while dealing with the distress of someone very close to
them facing an incurable disease.
Friends and family often struggle to show their support for
people living with ABC, and although they have good in-
tentions, many can do or say things that are misconstrued
or unhelpful to patients. Although patients reported that
they appreciate sympathy, at times, they feel that they are
defined by their disease and not regarded as an individual.
Patients emphasized the need to be included and
respected by their friends and family. Many shared that
they have been told they look great, to stay positive, or to
keep fighting, which often has an unintended but negative
impact on patients. Offering medical advice or suggesting
unconventional alternative treatments is another common
way that friends and family attempt to show support, which
can be confusing and unwelcome by patients, leading to
feelings of exasperation and unease.
Insights from the workshop highlight the need for greater
education and support for families and friends to enable them
to care for loved ones living with ABC. Several opportunities
were identified to support caregivers, family members, and
friends in the crucial role they play with patients:
• Developing educational materials specifically for families
and friends that outline information about the diagnosis
and practical guidance for day-to-day care could alle-
viate some of the burden caring for patients with ABC.
• Introducing families, friends, and caregivers to peer
groups and other resources could address some of the
psychologic and emotional challenges they face and allow
knowledge sharing between those affected by ABC.
Fallowfield et al
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• Involving primary caregivers as part of the care team
earlier could help them to feel validated and included
and not just passive recipients of information.
• Providing information at clinics and health care practices
could help to prepare caregivers for the challenges they
will face. In Australia, there is a project aiming to improve
HCP interaction with caregivers, on the basis of con-
sensus guidelines.26,27
Final Considerations
The variety of unmet needs discussed in the workshop
highlights that patients with ABC still face considerable chal-
lenges. Unfortunately, many of these are not new for patients
with ABC, yet remain unresolved.2 Findings demonstrate that
these issues continue to be common and widespread and will
not be resolved until tangible action is taken.
Challenges raised by participants may be magnified by
cultural, religious, geographical, and financial reasons.
Several issues are most prominent in developing countries
with limited resources including, but not limited to, access
to care and available treatments, costs of treatment, rela-
tionships with doctors, involvement in health care deci-
sions, traditional medicine over medical treatment, and
guilt, shame, and stigma associated with an ABC diagnosis.
Issues highlighted should be prioritized by working groups to
shape the development of community-based solutions.
Aligned with the ABC Global Alliance mission and vision, there
is a need for the global community to act proactively to
maximize awareness of these ongoing unmet needs and
existing resources, while socializing and building new initiatives
and resources to help close these gaps for patients. The fol-
lowing existing initiatives demonstrate steps toward addressing
challenges that patients with ABC face: the Seeding Progress
and Resources for the Cancer Community MBC Challenge
seeks to support country-specific innovative ideas and projects
from not-for-profit organizations that address the unmet needs
of patients with ABC.28 The Dandelion Toolkit uses visuals to
overcome communication barriers and help patients with ABC
to understand their disease and its implications, so that they
can make well-informed treatment decisions.29 The Global
Status of Advanced/Metastatic Breast Cancer 2005-2015
Decade Report revealed where there are substantial gaps in
care for patients with ABC.2 This report inspired “I’mstill here,”
an insights report on living with ABC in New Zealand, which
has been used to advocate for the approval of new drugs and
for the development and implementation of dedicated ABC
guidelines lacking in the country.30
Workshop attendees represented a range of different dis-
ciplines, including HCPs and patient advocates. Since the
predominant voice for patients in the workshop came from
patient advocates, who are likely to be more knowledgeable
and more informed than most patients, it is possible that the
data collected in this study and consequently the unmet
needs presented here are an underestimation of the actual
emotional and practical burden faced by patients living with
ABC. In the community, or outside of a formal workshop
setting, the unmet needs identified may be perceived dif-
ferently. Further patient-centered research is required to
understand the full extent and impact of the unmet needs of
ABC for both patients and their caregivers around the world.
TABLE 4. Key Unmet Needs Identified by the Multidisciplinary Group
Question Asked to the Multidisciplinary
Participant Group Key Unmet Needs Identified by the Multidisciplinary Participant Group
1. What I wish I had known about ABC and/or
MBC before my diagnosis.
A lack of information about diagnosis, recurrence, prognosis, and disease management, the impact
of ABC on everyday life, and availability of patient-focused resources
The need for advice about continuing to work, paying medical costs, making a will, and applying for
and receiving financial support
The terms advanced, metastatic, secondary, and stage IV are frequently used interchangeably by
HCPs and across different countries
2. Things I still do not understand about ABC
and/or MBC and treatment options
A lack of available and accessible advice on occupational, legal, and financial support (in addition to
the above points)
3. Things my health care professionals did
that helped or did not help
The need for deeper relationships with HCPs and a greater role in the decision-making process
A lack of sufficient empathy from health care teams
Uncertainty of who their primary point of contact should be and who to direct questions to
The need for both professional and peer psychologic support to be integrated into their care and a
lack of information on where to find peer support
Limited access to ABC clinical trials
4. Things that friends and family could do to
help when you have ABC
A lack of accessible guidance, resources, and support for caregivers, friends, and family
The need to be included and respected by their friends and family
The need for greater education and support for families and friends to enable them to care for loved
ones living with ABC
Abbreviations: ABC, advanced breast cancer; HCP, health care professional; MBC, metastatic breast cancer.
Gaps in Care and Support for Patients With ABC
JCO Global Oncology 981
Downloaded from ascopubs.org by University of Sussex on July 15, 2021 from 139.184.171.040
Copyright © 2021 American Society of Clinical Oncology. See https://ascopubs.org/go/authors/open-access for reuse terms.
TABLE 5. Opportunities to Improve Patient Understanding and Knowledge About ABC, Patient-HCP Relationships, and Support for Caregivers, Family
Members, and Friends
Question Asked to the
Multidisciplinary Participant Group
Summary of Key Unmet Needs Identified by the
Multidisciplinary Participant Group
Opportunities Identified by the Authors to Improve Patient
Understanding and Knowledge About ABC, Patient-HCP
Relationships, and Support for Caregivers, Family
Members, and Friends
1. What I wish I had known about
ABC and/or MBC before my
diagnosis
Significant patient knowledge gaps exist related
to the diagnosis and management of ABC, and the
availability of patient-focused information to
support these gaps in knowledge remains limited
Using patient-friendly language to assist patients with
EBC in their understanding of the risk of recurrence
and its impact on longer-term survival
Providing accurate and personalized information about
diagnosis and prognosis in an easily understood format
2. Things I still do not understand
about ABC and/or MBC and
treatment options
Directing patients to appropriate resources for further
research, such as patient advocacy or health service
websites, could enable improved self-education about
ABC and avoid the use of unreliable sources
Developing partnerships between health practices and
local patient groups to provide patients with
information and direction for occupational, legal, and
financial support specific to their country or region
could address some of the daily needs they face while
living with ABC
3. Things my health care
professionals did that helped or
did not help
The development of meaningful relationships between
patients and HCPs, and the role of patients in decision
making, can often be overlooked for patients with ABC
Taking time at the beginning of appointments to ask
patients open questions about their emotional well-
being and expectations for therapy could prompt them
to provide additional information that is useful when
developing a treatment plan
Explaining treatment options to patients and information
in an easy-to-understand manner could improve
patient satisfaction and outcomes. Cultural differences
should be considered, as individuals from some
cultures may feel uncomfortable about certain
approaches. Providing adequate written information
and links to available resources is key to allow patients
to further explore and digest information at home
Training HCPs in communication skills that foster
empathy could improve their ability to adopt a more
holistic approach that considers individual patient
needs and life circumstances
Asking patients how they prefer to receive information,
including test results—for example, via e-mail,
telephone, or face-to-face—could improve their
engagement
Multidisciplinary care approaches are crucial for patients
with ABC; however, these often lack effective
coordination; access to clinical trials for ABC also
remains limited
Providing contact details of the health care team,
including administrative members, nurses, and
physicians, and particularly the patients’ primary point
of contact, could create a channel for patients to ask
questions about their therapy and provide them with a
feeling of support and continuity
Providing patients with information on the availability of
professional psychologic services and local peer
support groups may help to manage the emotional
burden of living with ABC
Designing clinical trials focused on clinically relevant
questions, appropriate inclusion or exclusion criteria,
and meaningful end points could improve access to
trials for patients with ABC, while educating on the
positive outcomes
The generation of real-world data to complement clinical
trial data could help to bridge the current gaps in
epidemiologic and outcomes data for ABC
(Continued on following page)
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TABLE 5. Opportunities to Improve Patient Understanding and Knowledge About ABC, Patient-HCP Relationships, and Support for Caregivers, Family
Members, and Friends (Continued)
Question Asked to the
Multidisciplinary Participant Group
Summary of Key Unmet Needs Identified by the
Multidisciplinary Participant Group
Opportunities Identified by the Authors to Improve Patient
Understanding and Knowledge About ABC, Patient-HCP
Relationships, and Support for Caregivers, Family
Members, and Friends
4. Things that friends and family
could do to help when you have
ABC
Caregivers, friends, and family members do not receive
sufficient guidance to support patients with ABC and
manage their own well-being
Developing educational materials specifically for families
and friends that outline information about the diagnosis
and practical guidance for day-to-day care could
alleviate some of the burden caring for patients with
ABC
Introducing families, friends, and caregivers to peer
groups and other resources could address some of the
psychologic and emotional challenges they face and
allow knowledge sharing between those affected by
ABC
Involving primary caregivers as part of the care team
earlier could help them to feel validated and included
and not just passive recipients of information
Providing information at clinics and health care practices
could help to prepare caregivers for the challenges
they will face
Abbreviations: ABC, advanced breast cancer; EBC, early breast cancer; HCP, health care professional; MBC, metastatic breast cancer.
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